title: Thrombin enhances lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis.
abstract: To clarify the role of thrombin in fibroblast growth and the development of pulmonary fibrosis in bleomycin-induced interstitial lung disease, we examined the relationship of thrombin activity to fibroblast growth-stimulating activity (FGA) in bronchoalveolar lavage (BAL) fluid from bleomycin-treated rats. Male Wistar rats were given a single intratracheal injection of bleomycin, BAL was performed 2, 6, and 15 days later, and the BAL fluid was assayed for thrombin activity and FGA. Higher FGA than the control value was detected in the BAL fluid from rats on day 6 after bleomycin administration. In bleomycin-treated rats, thrombin activity in the BAL fluid was significantly elevated on day 2 and maximal on day 6. The FGA of the BAL fluid from bleomycin-treated rats on day 6 was significantly decreased by its treatment with various thrombin inhibitors, such as alpha 1-protease inhibitor, antithrombin III, hirudin, and MD-805. In our assay, purified rat thrombin also showed FGA in vitro, and its FGA was inhibited by the same concentrations of these thrombin inhibitors as those inhibiting the activity in the BAL fluid. On ammonium sulfate fractionation, most of the thrombin activity was recovered in the fraction of 35 to 50% saturation in which most of the FGA was detected. These results suggest that the FGA of the BAL fluid from bleomycin-treated rats was at least partly due to thrombin is responsible, at least in part, for fibroblast growth and pulmonary fibrosis in bleomycin-induced interstitial lung disease.
authors.affiliation: Third Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tani
authors.forename: S
authors.initials: S
authors.lastname: Yasuoka
authors.forename: F
authors.initials: F
authors.lastname: Ogushi
authors.forename: K
authors.initials: K
authors.lastname: Asada
authors.forename: K
authors.initials: K
authors.lastname: Fujisawa
authors.forename: T
authors.initials: T
authors.lastname: Ozaki
authors.forename: N
authors.initials: N
authors.lastname: Sano
authors.forename: T
authors.initials: T
authors.lastname: Ogura
mesh_terms: D000645:Ammonium Sulfate; D000818:Animals; D001761:Bleomycin; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000201:enzymology / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects / Q000473:pathology*; D006133:Growth Substances / Q000494:pharmacology*; D008168:Lung / Q000187:drug effects / Q000473:pathology*; D008297:Male; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000473:pathology*; D051381:Rats; D011919:Rats, Inbred Strains; D013917:Thrombin / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*
chemical_list: D006133:Growth Substances; D001761:Bleomycin; D013917:Thrombin; D000645:Ammonium Sulfate